Quarterly Transactions Made in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 7,215,787 | 5,191,632 | 12,407,419 | 8,497,886 | 3,678,699 | 12,176,585 | 230,834 | |
Q4 2021 | 10,934,921 | 3,174,496 | 14,109,417 | 6,815,366 | 3,990,391 | 10,805,757 | 3,303,660 | |
Q1 2022 | 12,912,975 | 3,152,046 | 16,065,021 | 8,624,242 | 7,322,006 | 15,946,248 | 118,773 | |
Q2 2022 | 6,534,983 | 1,995,819 | 8,530,802 | 11,296,410 | 641,501 | 11,937,911 | -3,407,109 | |
Q3 2022 | 9,171,500 | 3,243,756 | 12,415,256 | 6,603,807 | 1,371 | 6,605,178 | 5,810,078 | |
Q4 2022 | 7,186,970 | 2,440,939 | 9,627,909 | 4,960,551 | 20,217 | 4,980,768 | 4,647,141 | |
Q1 2023 | 14,804,892 | 10,658,590 | 25,463,482 | 13,634,066 | 0 | 13,634,066 | 11,829,416 | |
Q2 2023 | 9,331,480 | 2,168,434 | 11,499,914 | 9,020,173 | 960,595 | 9,980,768 | 1,519,146 | |
Q3 2023 | 12,666,293 | 11,766,441 | 24,432,734 | 10,644,025 | 960,595 | 11,604,620 | 12,828,114 | |
Q4 2023 | 14,399,449 | 6,097,387 | 20,496,836 | 8,139,119 | 0 | 8,139,119 | 12,357,717 | |
Q1 2024 | 11,141,885 | 5,148,190 | 16,290,075 | 7,264,698 | 0 | 7,264,698 | 9,025,377 | |
Q2 2024 | 13,930,040 | 4,818,629 | 18,748,669 | 9,188,839 | 0 | 9,188,839 | 9,559,830 | |
Q3 2024 | 9,984,704 | 4,236,821 | 14,221,525 | 11,815,392 | 0 | 11,815,392 | 2,406,133 |